United States - English - NLM (National Library of Medicine)

purdue pharma lp - naldemedine tosylate (unii: v1n8f1rvvo) (naldemedine - unii:03ksi6wlxh) - naldemedine .2 mg - symproic is indicated for the treatment of opioid-induced constipation (oic) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. symproic is contraindicated in: - patients with known or suspected gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation [see warnings and precautions (5.1)]. - patients with a history of a hypersensitivity reaction to naldemedine. reactions have included bronchospasm and rash [see adverse reactions (6.1)] . risk summary there are no available data with naldemedine in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. there is a potential for opioid withdrawal in a fetus when symproic is used in pregnant women [see clinical considerations]. symproic should be used during pregnancy only if the potential benefit justifies

United States - English - NLM (National Library of Medicine)

maia pharmaceuticals, inc. - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sulfites or sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for inj

United States - English - NLM (National Library of Medicine)

fosun pharma usa inc - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - zinc phosphide; malathion - ready-to-use bait - zinc phosphide ungrouped active 20.0 g/kg; malathion organophosphorus-dithiophospha other 0.11 g /kg - vertebrate poison

United States - English - NLM (National Library of Medicine)

mckesson medical-surgical inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 200 mg in 1 g - - skin protectant - for the treatment and/or prevention of diaper rash - temporarily protects and helps relieve minor skin irritation and itching due to rashes

United States - English - NLM (National Library of Medicine)

energique, inc. - zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - zinc 200 [hp_c] in 1 ml - to be used according to standard homeopathic indications.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

gentell, inc,. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 0.2 kg in 1 kg - helps treat & prevent diaper rash. protects chafed skin assoicated with diaper rash & helps protect from wetness. effective for treating poison ivy, poison oak & sumac. helps, treats and prevents diaper rash. protects chafed skin associaed with diaper rash & helps protect from wetness. effective in treating poison ivy, poison oak and sumac.

United States - English - NLM (National Library of Medicine)

mckesson medical-surgical - zinc oxide 25% -

United States - English - NLM (National Library of Medicine)

mckesson medical-surgical - zinc oxide 25%, calamine 1% - skin protectant - dries the oozing and weeping of poison ivy, poison oak, or poison sumac. - ideal for the managing extremities (e.g. varicose ulcers) requiring protection and support.

United States - English - NLM (National Library of Medicine)

vi medical products, inc - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - zinc cation 10 g in 100 ml - uses - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. - stop use and ask a doctor if rash occurs